U.S. Capital Markets Stock News

Alliance Resource Partners (NasdaqGS:ARLP) completed the acquisition of significant interests in AllDale Minerals III and IV. The deal expands ARLP's oil and gas royalty position, with added exposure to the Permian Basin. The transaction represents a sizeable capital deployment into the company's royalties segment. Alliance Resource Partners has historically been known for its coal operations, and the move into additional oil and gas royalties marks a wider energy footprint for the...

Sphere Entertainment has delivered very strong share price gains over the last three years, yet the valuation signals are pulling in different directions, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside while market based multiples look stretched. Sphere Entertainment has returned roughly 387.2% over three years, which puts a spotlight on whether recent gains already reflect most of the good news in the story. Expectations around demand for The Wizard of...

In recent weeks, TransMedics Group has drawn attention as its Organ Care System and National OCS Program gained traction amid rising U.S. heart, liver, and lung transplant volumes and ongoing expansion into kidney transplants and European logistics infrastructure. This combination of increased transplant activity and scaled, vertically integrated transport capabilities highlights how TransMedics is reshaping the operational backbone of organ transplantation. We’ll now examine how rising...

When the Federal Reserve itself becomes the story, large U.S. financial stocks can quickly move from routine holdings to high conviction opportunities or clear avoids. With Kevin Warsh stepping in as Fed Chair and fresh legal challenges to central bank independence in focus, investors are reassessing which institutions may be better positioned if policy priorities, rules or communication change. This article looks at the Fed shockwaves and how they connect to some of the biggest U.S...

Exelixis (EXEL) has come back into focus after being removed from several Russell 1000 defensive style indices. This shift may influence how some quantitative and index-linked investors treat the stock. See our latest analysis for Exelixis. Beyond the index changes, Exelixis has seen firm buying interest, with a 27.28% 3 month share price return and a 28.16% year to date share price return at a last close of US$55.85. The 5 year total shareholder return of 210.11% reflects how the long term...

Copa Holdings stock has delivered a strong 153.8% return over the past 5 years, and with the shares recently closing at US$152.65, the key tension for investors is whether that performance is already reflected in the price or if the current valuation still leaves room for a margin of safety. The 153.8% return over 5 years suggests Copa Holdings has already rewarded long term holders, which naturally raises the bar for any new buying decision. Future earnings and cash flow from Copa Holdings'...

With the Trump administration increasing pressure on the Federal Reserve, including efforts to reshape its leadership and influence regional policy, US regional banks sit closer to the action than most sectors. Shifts in rate expectations, questions around Fed independence, and potential changes at key regional Fed branches can all feed into funding costs, loan growth, and investor sentiment toward the sector. This article looks at 3 stocks from a US Regional Banks screener that appear...

Carrier Global stock has delivered a 55.3% gain over the past five years, yet today's $70.07 share price sits in the middle of a valuation split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples paint a richer picture. Over five years, Carrier Global has returned 55.3%, which puts recent short term weakness into the context of a longer, positive compounding story for shareholders. The recent $440 million sale of the Riello...

Immunocore Holdings stock has bounced in the short term yet, after a share price that is still down about 47.8% over three years and a mixed result from the valuation checks, the current level around US$32.50 raises questions about how much upside is already priced in. Over the past three years, Immunocore Holdings has declined roughly 47.8%, which suggests investors who bought earlier in the period have faced a material capital loss that the recent rebound has not fully offset. Fresh Phase...

Dennis S Hudson III Revocable Trust previously filed a Form 144 to sell 8,000 Seacoast Banking Corporation of Florida shares on June 16, 2026, for about US$251,316.80, signaling a planned insider transaction rather than a confirmed trade. At the same time, Seacoast’s low and stagnant net interest margin, stalled earnings per share growth, and flat tangible book value per share have drawn attention to the bank’s profitability and asset growth challenges despite earlier revenue...

Hamilton Insurance Group (NYSE:HG) is back in focus after being removed from the Russell 2000 Dynamic Index, even though the stock recently outperformed broader indexes and drew attention for its value metrics. See our latest analysis for Hamilton Insurance Group. Over the past year, Hamilton Insurance Group has built clear positive momentum, with a 1-year total shareholder return of 72.29% and a 26.29% year to date share price return. The recent $34.44 share price sits alongside index...

SFL (SFL) has ordered a 7,000-CEU LNG dual-fuel Pure Car and Truck Carrier for delivery in 2029, aligning its fleet with tighter environmental requirements and increasing demand for global car shipment capacity. See our latest analysis for SFL. Alongside the new LNG dual-fuel carrier order, SFL has been added to several Russell growth benchmarks. The stock’s share price return has moved 34.22% year to date, with a 5 year total shareholder return of 123.64%, suggesting momentum has been...

Diversified Energy Company (NYSE:DEC) was recently added to the Russell 2000 Defensive and Russell 2000 Value-Defensive indices and has continued cancelling shares under its ongoing buyback program, reducing its common stock in issue to about 70,760,082 shares. These index inclusions and active repurchases are reshaping the company’s investor base and share count, potentially amplifying the market impact of its capital allocation choices. With Diversified’s recent index inclusions and...

Earlier this year, iRhythm Technologies reported quarterly revenue that came in 2.8% above analyst expectations and reaffirmed full-year guidance in line with consensus, underscoring steady demand for its AI-enabled Zio cardiac monitoring platform. The muted investor reaction, despite the revenue beat, suggests the market may have been anticipating even stronger signals on growth or profitability from iRhythm’s update. We’ll now examine how this revenue beat but only in-line guidance could...

In recent months, analysts upgraded Perdoceo Education, highlighting Q1 2026 revenue of US$221.7 million, net income of US$54.0 million, and management guidance for full-year 2026 EPS of US$2.86–US$2.97 supported by broad-based enrollment growth. An interesting angle for investors is how this stronger earnings outlook and favorable valuation grades are reinforcing perceptions of Perdoceo as comparatively attractive within its education peer group. We’ll now examine how the stronger...

Unicycive Therapeutics recently disclosed that the FDA issued another Complete Response Letter for its resubmitted New Drug Application for oxylanthanum carbonate, citing unresolved deficiencies at a third-party manufacturing vendor but raising no new safety or efficacy concerns and requesting no additional clinical data. This outcome underscores how non-clinical factors such as manufacturing compliance and vendor inspections can critically influence the regulatory path of a late-stage...

What the latest board changes mean for Columbia Financial stock Columbia Financial (CLBK) recently drew investor attention after shareholders approved the election of Dennis E. Gibney and James H. Wainwright as Directors at the company’s June 25, 2026 annual meeting. This board refresh comes as Columbia Financial is pursuing a second step conversion to a fully public stock holding company and an acquisition of Northfield Bancorp, with related stock offerings and regulatory approvals in...

In late June 2026, First Hawaiian, Inc. was removed from the Russell 1000 Dynamic Index shortly after reporting quarterly results that were broadly in line with expectations but slightly ahead on net interest income and earnings per share. This combination of index removal and an earnings beat underscores how company-specific fundamentals can still influence sentiment toward regional banks facing structural industry pressures. Next, we’ll examine how First Hawaiian’s recent earnings beat on...

PepsiCo (NasdaqGS:PEP) is participating in the RegenLend pilot program, providing farmers with access to equipment leases to support regenerative agriculture across its supply chain. The company has also partnered with Captain D's on the Alaska Family Cruise Sweepstakes, highlighting responsibly sourced Alaska seafood in a national consumer promotion. PepsiCo, trading at $144.22, is adding fresh detail to its sustainability story through these new agriculture and sourcing initiatives. For...

The Trump administration proposes a ban on new Chinese-made solar inverters, citing cybersecurity concerns. The policy, if implemented, could shift demand toward SolarEdge Technologies and other non-Chinese manufacturers. This development is relevant for NasdaqGS:SEDG investors watching policy driven shifts in the solar supply chain. SolarEdge Technologies sits at the center of this policy discussion, with its NasdaqGS:SEDG shares recently trading at $52.38. The stock is up 67.0% year to...

Lindsay (LNN) has put Q3 2026 on the board with revenue of US$160.8 million and basic EPS of US$1.54, while trailing twelve month revenue sits at US$627.9 million and EPS at US$5.22, setting the backdrop for how investors read the latest earnings run rate. The company has seen quarterly revenue move from US$169.5 million in Q3 2025 to US$160.8 million in Q3 2026, with basic EPS shifting from US$1.80 to US$1.54 over the same period. Those trends now feed directly into the discussion around...

FedEx Freight Holding Company has declined about 4.4% over the past month, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the stock trading at a discount, raising the question of how much of that gap is justified by its fundamentals. The share price is down 4.4% over the past month, which may suggest investors are still reassessing the story after recent weakness. The agreed US$1.4b sale of FedEx's supply chain unit to CMA CGM can...

Iovance Biotherapeutics recently updated its corporate presentation, reaffirming 2026 revenue guidance of US$350 million to US$370 million and highlighting a cash runway into 2028 alongside growing commercial adoption of Amtagvi in advanced melanoma. The company also underscored its expanding treatment footprint with more than 1,500 patients treated and over 90 authorized centers, while advancing clinical programs across lung, endometrial, and other solid tumors. We will now examine how...

Clover Health Investments (CLOV) is back in focus after Q1 results that beat revenue expectations, came with higher full year EBITDA guidance, strong customer additions, and a higher Medicare star rating following a favorable court ruling. See our latest analysis for Clover Health Investments. Clover Health Investments has seen sharp share price swings, with a 30 day share price return of 31.83% and a 90 day share price return of 205.81%, while the 1 year total shareholder return of 105.47%...